CJC-1295 No DAC, combined with Ipamorelin, is a dual peptide blend studied for synergistic stimulation of endogenous growth hormone release through complementary receptor activation pathways.
CJC-1295 No DAC, combined with Ipamorelin, is a dual peptide blend studied for synergistic stimulation of endogenous growth hormone release through complementary receptor activation pathways.
$75.00
This research blend combines CJC-1295 No DAC, a growth hormone-releasing hormone analog, with Ipamorelin, a selective ghrelin receptor agonist. Together, they are examined for their ability to stimulate physiologic growth hormone pulsatility through separate yet complementary mechanisms.
CJC-1295 targets GHRH receptors in the anterior pituitary, while Ipamorelin selectively activates ghrelin or GHS receptors without significantly influencing cortisol or prolactin levels in controlled models. Researchers utilize this combination in studies focused on growth hormone signaling, recovery pathways, sleep cycle regulation, lean tissue modeling, and metabolic adaptation. Supplied in 3ml format, this product is intended strictly for laboratory research use only.
tristackpeptides@gmail.com
All products are supplied strictly for research and laboratory use only. They are not intended for human or veterinary consumption. We do not provide or support any information regarding personal use or administration.